Universal Corporation

Universal Corporation Earnings Recaps

UVV Consumer Staples 2 recaps
Next earnings: August 5, 2026 (estimated) · full calendar
Q4 2026 May 31, 2026

Universal's shares inched up 1.4% post-earnings, reflecting a report that balanced modest revenue growth against significant noncash impairment charges and inventory write-downs, which constrained profitability and tempered investor enthusiasm.

Key takeaways
  • Fourth quarter consolidated revenue rose 2% year-over-year to $715 million; full year revenue was $2.9 billion, slightly lower than the prior year.
  • Operating loss of $15 million in Q4 versus $43 million operating income a year ago; full year operating income declined $64 million to $169 million, largely due to a $41 million goodwill impairment at Shank’s Ingredients segment and inventory write-downs in dark air-cured tobacco.
  • Net loss attributable to Universal was $43 million in Q4, compared to net income of $9 million last year; full year net income dropped to $33 million from $95 million.
  • Tobacco segment revenue increased 3% in Q4 to $632 million but segment operating income declined from $46 million to $27 million, pressured by $43 million in inventory write-downs versus a $19 million charge last year.
  • Ingredients segment revenue declined to $83 million in Q4 with operating income halving to $2 million; full year segment operating income fell sharply to $3 million from $12 million, weighed down by weaker Shank’s performance.
Q3 2026 Feb 10, 2026

Universal Corporation reported mixed results in Q3 FY 2026, with a decline in tobacco segment revenues and higher costs compressing margins in ingredients operations, despite maintaining solid overall performance.

Key takeaways
  • Q3 consolidated revenue decreased to $861.3 million, down from $937.2 million year-over-year.
  • Operating income fell to $82 million, compared to $104.1 million in the same quarter last year.
  • Revenue from tobacco operations dropped to $779.9 million, with segment operating income declining significantly to $84 million.
  • Ingredients operations recorded a slight revenue decrease but moved to an operating loss of $100,000 due to increased fixed costs and market challenges.
  • The company successfully refinanced and upsized its credit facility, boosting liquidity to $917 million and strengthening financial flexibility.